electroCore to Participate at the Needham Virtual Healthcare Conference
electroCore (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, has announced its participation in the upcoming Needham Virtual Healthcare Conference on April 10, 2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
electroCore (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, has announced its participation in the upcoming Needham Virtual Healthcare Conference on April 10, 2025.
CEO Dan Goldberger and CFO Joshua Lev will deliver a group presentation at 2:15 p.m. ET and engage in one-on-one meetings throughout the conference day. The presentation will be accessible via live audio webcast, with a replay option available.
Investors interested in meeting with management during the conference can arrange meetings through their Needham representative or by contacting FNK IR at ecor@fnkir.com.
Details
News Market Reaction – ECOR
The recorded move for ECOR in the trading session of this news was -7.47%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
ROCKAWAY, N.J., April 01, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate at the Needham Virtual Healthcare Conference taking place virtually on April 10, 2025.
Dan Goldberger, CEO and Joshua Lev, Chief Financial Officer, will host a group presentation at 2:15 p.m. ET and participate in one-on-one meetings throughout the day.
DATE: April 10, 2025
TIME: 2:15 p.m. ET
WEBCAST: electroCore Group Presentation
A live audio webcast and replay of the presentation will be available using the above dedicated link. Investors attending the conference who are interested in scheduling a meeting with management can do so by contacting their Needham representative, or by emailing FNK IR at ecor@fnkir.com for more information.
About electroCore, Inc.
electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company dedicated to improving health through its non-invasive vagus nerve stimulation (“nVNS”) technology platform. Our focus is the commercialization of medical devices for the management and treatment of certain medical conditions and consumer product offerings utilizing nVNS to promote general wellbeing and human performance in the United States and select overseas markets.
For more information, visit www.electrocore.com.
Contact
ECOR Investor Relations
(973) 302-9253
investors@electrocore.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.